Surgical rehabilitation of Graves’ orbitopathy

Published on 08/03/2015 by admin

Filed under Opthalmology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3682 times

CHAPTER 54 Surgical rehabilitation of Graves’ orbitopathy

See Video image

Introduction

Graves’ orbitopathy (GO) is one of the phenotypic appearances of Graves’ disease, a multisystem disorder which usually leads to hyperthyroidism and goiter, less frequently to GO, and rarely to pretibial myxedema and acropachy. GO is the most frequent and important extrathyroidal expression of Graves’ disease. It may also be found, although less frequently, in patients with no present or past history of hyperthyroidism (so-called euthyroid or ophthalmic Graves’ disease), or in patients who are hypothyroid due to chronic autoimmune (Hashimoto’s) thyroiditis1,2. In most affected individuals GO is mild and self-limiting, and only in 3–5% of cases is it severe and potentially sight threatening1,3.

The exact pathogenesis of GO is unknown47. It is, however, worth highlighting the clear-cut link between the orbit and the thyroid, because this has important clinical and therapeutic implications8. In addition to endogenous (non-preventable) determinants, such as genetics, age- and gender-related factors9, GO occurrence and progression are influenced by environmental (preventable) factors, such as cigarette smoking, thyroid dysfunction, and different treatments for hyperthyroidism3,10. This implies that control or correction of these risk factors is an integral part of GO management.

Independently of the complex association with thyroid dysfunction and its treatment, management of GO is difficult: decisions need to be made regarding the need for specific treatment or whether spontaneous regression is likely.

The natural history of GO is of gradual increase in severity followed by a plateau phase then gradual improvement11. These are the active phases. The inactive phase follows with no change in severity. GO is thus self-limiting, although it often does not return to baseline. Treatment is aimed at accelerating recovery, preventing serious sequelae, and eventually functional and cosmetic rehabilitation.

Therapeutic options consist of medical therapy, radiotherapy, surgery, or frequently a combination of these. Consensus as to indications and timing of these options has been reached by the EUGOGO consortium (Fig. 54.1)12,13.

Timing of surgery

Surgery may be necessary to protect visual function in the active phase or to correct the stable typical disfigurement and symptoms in the static post-inflammatory phase of the disease.

The first rehabilitative step mainly consists of orbital bony decompression. It causes reduction in exophthalmos as well as reduction in upper and lower eyelid displacement14. It may positively influence extraocular muscle restrictions, but displacement and scarring of the soft orbital tissues caused by decompression surgery may also cause strabismus. Possible squint surgery should therefore follow orbital decompressions, but considering that vertical tropias may influence eyelid position, squint surgery should precede possible eyelid corrections. Finally, when necessary, the finishing touch can be given by eyebrow lift, forehead plasty, and blepharoplasty.

In short, surgical rehabilitation needs to respect the given order since the preceding step may influence the necessity and the extent of the step that follows. When all the steps are necessary, the entire rehabilitation may require between 1.5 and 2 years. In particular cases, exceptions are possible and the rehabilitation can be favorably speeded up by carrying out more than one procedure at the same time15. The traditional management algorithm has not been respected in only a few series1620, and it has met with vigorous criticism21.

Orbital decompression

The autoimmune process at the basis of GO induces swelling of the soft tissues contained within the boundary of the bony orbit; this causes impairment of the venous outflux towards the cavernous sinus and reverses the flux in the direction of facial circulation.

This positive feedback circle leads to an increase in the intraorbital pressure, which is first responsible for the progression of GO and later for its typical signs and symptoms5. Any surgical procedure aimed at decreasing the raised intraorbital pressure and its effects by means of enlargement of the bony orbit and/or removal of the orbital fat is defined as orbital decompression.

Orbital decompression is currently indicated for the treatment of optic neuropathy refractory to medical therapy, exposure keratopathy unresponsive to local measures and/or minor eyelid surgeries, disfiguring exophthalmos and symptoms. Eyeball subluxation (which may be a possible cause of acute optic neuropathy and exposure keratopathy) postural visual obscuration in patients with congestive inactive GO and recently onset choroidal folds due to eyeball indentation by enlarged extraocular muscles represent other functional indications for decompression surgery22.

Osteotomies can involve the medial, and lateral orbital walls and the orbital floor (Fig. 54.2); lipectomies can be performed at the level of all the orbital quadrants (Fig. 54.3). Decompression surgery can be performed through several different surgical incisions (Fig. 54.4) preferably under general anesthesia.

The inferior fornix incision is an extremely popular approach to orbital decompression. It can be extended medially into a transcaruncular incision and can be associated with an incision at the lateral canthus that permits the lower lid to swing outwards, thus easing the exposure of the lateral wall. This latter association, first described by McCord in 1981, is known as ‘swinging eyelid’23. This combination of periorbital incision permits an easy approach to the orbital floor, medial, and lateral walls and lipectomies from the inferior orbital quadrants.

As an alternative, an upper skin crease incision can be used separately or in combination with the pure inferior fornix or with the swinging eyelid approach in order to address the lateral orbital wall through a wider exposure, and to have access to the upper fat compartments of the medial and lateral quadrants.

The coronal approach is a more invasive procedure which, however, offers the widest access to the lateral orbital wall24, and it may have distinctive advantages in a number of situations including the presence of remarkable periorbital swelling or conjunctival chemosis, the necessity of minimizing the number of periorbital incisions, or the necessity of extensive manipulation of the lateral wall (including its rim)25,26. Through a coronal incision, brow lift, and correction of frontal/glabellar rhytids, which are often necessary in patients with GO, can be performed simultaneously with orbital decompression, thus favorably speeding up the timing of rehabilitative surgery25,27.

Orbital decompression by transinferior fornix/transcaruncular/swinging eyelid: surgical technique

Step 1. After the exposure of the inferior fornix by means of a Desmarres retractor and a malleable orbital retractor, the conjunctiva and lower lid retractor complex are transected en bloc with a Colorado needle and the periorbit of the inferior orbital rim is exposed (Fig. 54.5A). During this step, and in all those which imply the use of a Colorado needle, the part of the retractors in contact with tissues should be rubber coated or isolated by means of sterile plasters in order to avoid unwanted burn to the eye, eyelids, and extraocular muscles.
Step 2. The exposed periorbit is incised and the orbital floor and the medial and orbital wall exposed by developing a subperiorbital plane (Fig. 54.5B,C). In order to obtain the best possible exposure of the medial wall, the bony insertion of the inferior oblique muscle may be detached without consequences, and if required the conjunctival incision extended upwards, laterally to the caruncle. A separate incision lateral to the caruncle (transcaruncular approach)28 can possibly be used to address the medial orbital wall when the floor is not to be removed.
Step 3. After this a Frazier suction tip is used to fracture the delicate bone of the medial orbital wall and the floor and Blakesley forceps no. 1 and no. 2 are used to remove bony fragments and mucosa of the sinuses (Fig. 54.5D). The inferomedial osteotomy extends between the frontoethmoidal suture (orbital landmark of the inferior limit of the anterior cranial fossa) and the inferior orbital fissure. The bulla ethmoidalis is opened towards the orbit from the posterior lacrimal crest up to the orbital apex, and then the orbital floor medial to the infraorbital canal is removed from about 1 cm behind the inferior orbital rim up to the posterior wall of the maxillary sinus. The bony infraorbital canal, the floor lateral to it (Fig. 54.5E), and the posterior two-thirds of the maxillary ethmoidal strut can also be removed. The anterior one-third of the strut should be left intact in order to prevent globe displacement and the possibility of medial entropion.
Step 4. In order to implement the effect of decompression fat can be removed from the medial and lateral inferior quadrants (Fig. 54.6). An adequate exposure attained by the assistant, by means of electrically insulated Desmarres retractor and different sized malleable orbital spatulas, aids the surgeon to perform the lipectomy by exerting gentle traction on the fat with fine toothed forceps simultaneously dissecting it with a Colorado needle. Fat can be removed up to the limit of the intraconal space (see Fig. 54.3). Lipectomies can also precede step 2 in order to aid subsequent bone exposure, and can be alone sufficient to attain an adequate decompression effect.
Step 7. The pure transinferior fornix incision is not sutured; tissues are simply repositioned (Fig. 54.5F). Where the conjunctival incision is extended upwards, laterally to the caruncle, such an extension may require two to three interrupted 8.0 absorbable sutures to adequately reapproximate the conjunctiva. Where a lateral canthotomy and inferior cantholysis is performed, the lateral canthal tendon should be reapproximated to the periosteum of the lateral orbital rim with a 5.0 long acting absorbable suture. Orbicularis muscle and skin are closed in layers respectively with 6.0 long acting absorbable and 6.0 non-absorbable sutures, or at the same time by means of 6.0 vertical mattress non-absorbable sutures. Skin sutures can be removed 5–7 days after surgery; vertical mattress sutures are removed later, approximately at postoperative day 10.

Orbital decompression by upper skin crease approach: surgical technique

Step 4. Zygomatic temporal and facial neurovascular bundles are coagulated by means of diathermy forceps and the lateral orbital osteotomy initiated with a surgical high speed drill equipped with a cutting-burr or a diamond-burr tip. A first sulcus is carved from just inside the lateral orbital rim, to the head of the superior orbital fissure (see Fig. 54.7D). It should run parallel to the plane of the orbital roof. A second sulcus is then carved from the head of the superior to the head of the inferior orbital fissure. The bone interposed between the two sulci and the lateral orbital rim is then removed leaving a small frame of bone at the level of the orbital rim. Finally the osteotomy is carefully extended superiorly and deeply by removing the spongious bone of the greater wing of the sphenoid up to its inner table or small spots of dura mater encephali are exposed.

Orbital decompression by coronal approach: surgical technique

Step 1. After razoring the hair and marking, a coronal incision is made with a No. 10 blade from ear to ear, 4–5 cm behind the hairline (Fig. 54.9A). In the central portion of the skull a subperiosteal plane is created by blunt dissection and laterally a surgical plane is bluntly developed between the deep and the superficial temporalis fascia (Fig. 54.9B). Laterally and inferiorly, where the deep temporalis fascia divides into a deeper and a more superficial layer to enclose Yasargil’s superficial temporal fat pad (which contain the branches of facial nerve), the surgical dissection is carried out alongside the medial surface of the deeper division of the fascia (Fig. 54.9C). The forehead flap thus created is then turned down in order to expose the superior and lateral orbital rims. Bleeding from the wound edges is controlled with Raney scalp clips (see Fig. 54.9B,C).
Step 2. The supraorbital nerve (Fig. 54.9D) is set free by chiselling its bony foramen when present (Fig. 54.9E) and the periorbita, including the trochlea, is dissected off the orbital bones.

Possible complications of decompression surgery

Despite their invasiveness, bone and fat orbital decompressions are safe procedures. Common complications of this surgical approach are consecutive strabismus, infraorbital hypoesthesia and sinusitis, lower lid entropion, and eyeball dystopia. Leakage of cerebrospinal fluid, infections involving the central nervous system, damage to the eye and optic nerve or their vasculature, cerebral vasospasm, ischemia, and infarction are severe but rare events. Reactivation of GO after rehabilitative bony orbital decompression and infraorbital pain are other rare complications22.

In addition to complications common to orbital decompressions in general, different surgical approaches may carry the risk of specific complications. The coronal approach leaving the eyelid undisturbed is less likely than periorbital incisions to create complications, which may potentially be harmful to the eye. Periorbital scarring with iatrogenic lid retraction and cicatrical lagophthalmos, eyelid margin malpositions, and ptosis (although rare) are more likely to occur with periorbital incisions. On the other hand, temporal bossing, damage to the frontalis nerve, scarring and alopecia at the site of the scalp incision, or effects upon ischemic areas of the frontal flap after healing by secondary intention, may complicate the coronal approach25.

Most of the possible complications cannot be predicted and their prevention is based on recommendations which are not specific in nature, and which include careful manipulation of the orbital content, accurate dissection of the orbital fat, and avoidance of expandable hemostatic agents and/or extensive use of diathermy within the orbit22.

Complications with known pathogenesis such as sinusitis can be simply prevented by taking care to create adequate sinus aeration as a part of the surgical procedure at the time of bone decompression22.

The occurrence of other complications, namely sinuses atelectasis, infraorbital hypoesthesia or pain, eyeball dystopia leakage of cerebrospinal fluid, and possible consecutive infectious involvement of the central nervous system, can be reduced by means of accurate evaluation of preoperative imaging, adequate planning of surgical intervention, and the use of prophylactic antibiotics22.

Correction of lid retraction

In GO, upper and lower lid retraction are due to a combination of inflammation, fibrosis, adrenergic stimulation, and restriction of the vertical rectus muscles. Exophthalmos also contributes in increasing the eyelid aperture by displacing either the upper or the lower lid14. Correction of upper or lower lid retraction implies recession of the lid retractors. Spacers are not essential for upper lid-lengthening procedures, but are necessary to provide height and the necessary stiffness to support the lower lid against gravity when it is severely retracted. A number of autologous, homologous, xenogenic, and synthetic materials have been used including ethanol-preserved donor sclera, upper lid tarsus, cartilage grafts, porous polyethylene, polytetrafluoroethylene or polyester meshes. Autogenous hard palate mucosal graft is relatively easy to obtain, is similar to lower lid tarsus in terms of thickness and stiffness, has a mucosal surface, has no risk of rejection, and undergoes minimal shrinkage following grafting. Ophthalmic complications of hard palate mucosal grafting are uncommon and morbidity at the donor site is rare29. Hard palate mucosal graft providing structural and epithelial elements represents an elective material for posterior lamella augmentation in lower lid lengthening. Homologous acellular dermal matrix with an appropriate consistency for posterior lamella augmentation is an optimal alternative to hard palate mucosa; unfortunately it is not readily available throughout Europe.

The treatment of persistent upper eyelid retraction is mainly surgical and far less predictable than that of lower lid. The medical therapy with topical alpha-blocker eye drops or with post-ganglial adrenergic blocker drugs is scarcely effective or connected to side effects. Botulinum toxin is an effective option, but its effect is limited in time and repeated injections are necessary. Temporary under- or over-correction, deficit of elevation, and paralysis of the orbicularis muscle can occur. The latter two being highly undesirable side effects in GO patients who are at risk for corneal exposure.

Upper eyelid lengthening is one of the last steps of the long-lasting surgical rehabilitation of patients with GO and, despite several surgical techniques being currently in use, an ideal method is lacking. For this it can be worth considering the use of the simplest and less time consuming technique. Sutureless Müllerectomy, transconjunctival or transcutaneous (blepharotomy) free en-bloc recession of levator complex and conjunctiva fulfil these criteria and can be used systematically for mild to moderate and for moderate to severe degrees of upper lid retraction respectively.

Lower eyelid lengthening

Hard palate mucosal graft harvesting: surgical technique

Selection of candidates prior to surgery is mandatory. Any lesion suspected for malignancy should be biopsied; oral candidiasis in immunocompromised patients should be cured in order to avoid delayed granulation at the donor site; the presence of exostosis such as torus palatinus or prominent palatal roots of teeth should be considered since the thin overlying mucosa of these areas may lead to unwanted periosteal or root damage at surgery. The presence of a bifid uvula or a muscular diastases of the soft palate can be an important clue to an underlying bony palatal cleft that is not otherwise evident, but which represents an absolute contraindication for mucosal harvesting. The presence of small isolated clefts of the bony palate are asymptomatic, and may escape clinical detection. Besides infectious causes and, iatrogenic damage to the bone and periosteum, oral–nasal fistulas may also develop from such malformations. Alcoholic and immunocompromised patients can also be at risk for delayed granulation at the surgical site and fistulas.

Local anesthesia is possible, but general anesthesia is preferred for the patient’s comfort.

image image

Fig. 54.10 (A) Location and aspect of the donor sites of the hard palate mucosal grafts 3 weeks after surgery; the defects at the site of harvesting have almost completed the healing process by granulation. (B) A custom-made acrylic palatal stent.

Reproduced with permission. Baldeschi L. Correction of lid retraction and exophthalmos. In: Brewitt H, Geerling G, eds. Scientific Evidence and Guidelines for the Clinical Management of Dry Eye Associated Ocular Surface Disease. Basel: Karger, 2007:103–26.

Lower lid lengthening: surgical technique

Upper lid lengthening

Sutureless transconjunctival müllerectomy: surgical technique

Sutureless transconjunctival müllerectomy is an effective procedure for the cure of mild degrees of upper eyelid retractions up to 2–3 mm. It does not interfere with the position of the skin crease since surgical dissection is carried out under the levator aponeurosis. It is a fast procedure that takes about 10 minutes per eyelid. Reintervention for under- or over-correction is rare and usually due to surgical mistakes like an incomplete excision of Müller’s muscle or damage to the aponeurosis of the levator muscle. Tear secretion may be reduced after müllerectomy; nevertheless, the risk of dry eye is low, and counterbalanced by the usually good functional and cosmetic results of the procedure.

Step 5. The distal insertion of the Müller’s muscle is gently cauterized, and afterwards severed with scissors. The isolated Müller’s muscle (Fig. 54.12D) is then removed by similarly severing its proximal insertion. At the end of the procedure the conjunctiva is not sutured. This prevents possible suture-related corneal erosions and leaves a natural drainage with reduction of postoperative ecchymosis.

Free en bloc recession of conjunctiva–levator complex by anterior (blepharotomy) or sutureless posterior approach

Upper eyelid lengthening by means of blepharotomy was developed by Leo Koornneef, but because of his untimely death he was unable to publish his idea; a large series published by one of his fellows contributed to popularize the technique30.

Free en bloc resection of conjunctiva–levator complex performed via an anterior or a sutureless posterior approach is an effective technique for the treatment of medium to severe degrees of upper lid retraction. The results are, however, not always predictable and reintervention may be necessary.

Success can be implemented by controlling intraoperative factors with potential effect on the final result. Intravenous sedatives interfere with the alertness of the patient and with his collaboration in setting eyelid position; thus these drugs should be used only when it is strictly necessary. Povidone iodine is an adrenergic-blocking agent. Preoperative irrigation of the conjunctival sac with this solution can potentially result in a paralysis of Müller’s muscle and should therefore be avoided. Paralysis of the levator and orbicularis muscle induced by local anesthetic and the contraction of Müller’s muscle induced by local anesthetics containing epinephrine are variables that may interfere with the position of the upper eyelid. These variables can be partially controlled if the dose of anesthetic, its epinephrine concentration, the sites, and the pressure of injection are maintained constant.

In order to account for the effect of gravity on the eyelid height, this is assessed with the patient in an upright position. The anterior approach gives good exposure; however, meticulous skin suturing is required to avoid formations of fistulas. The posterior approach is unsuitable in severe retraction, which does not allow an eversion of the eyelid, but it is the first choice in dark-skinned patients in whom unpleasant scars may result from transcutaneous approaches.

A full-thickness incision of the conjunctiva–levator complex may easily create a flat eyelid contour, if dissection is carried out too medially. In order to prevent a flat contour a central bridge of conjunctiva can be left at the level of the pupil. Careful medial dissection also prevents possible nasal droops that are often difficult to correct.

In the event of early retraction after surgery, the patient should be instructed to massage the lid downward while looking upward in order to maintain the eyelid at the desired position.

Blepharotomy: surgical technique

Step 10. The blepharotomy is closed by carefully suturing the skin only, with a running interlocked 6-0 non-absorbable suture, which should stay in place for 1 week (Fig. 54.13I). As for müllerectomy, the conjunctiva is not sutured. This leaves a natural drainage, preventing possible ecchymosis, suture-related corneal erosions, and compensates for possible conjunctival shortening due to long-lasting lid retraction.

Posterior approach: surgical technique

Squint surgery

Double vision due to dysthyroid strabismus is the factor which more than any other adversely affects the quality of life of patients with GO.

Under the definition of dysthyroid strabismus, there is restrictive strabismus due to GO (primary strabismus), and that induced by rehabilitative or functional orbital decompression (secondary strabismus). Primary strabismus can be worsened, or ameliorated by functional or rehabilitative decompression.

Small angle strabismus may benefit from prismatic lenses, while stable, larger angle strabismus requires surgical treatment.

Surgery aims at restoring fusion in the primary position of gaze and then at correcting residual incapacities. In order to achieve these goals, muscle recessions followed by retroequatorial myopexias are usually used. Oblique muscle surgery is rarely necessary. Complications are infrequent.

Surgical techniques are similar to those described in Chapter 57; in the case of dysthyroid strabismus muscle recession is often generous. In such cases, in order to maintain the contact arch, extraocular muscle tendon elongation should be done. It can be attained by means of autologous or donor fascia grafts sutured between the recessed muscle tendon and the eye globe, or more simply by recessing the muscle by means of hang-back loops attained with sutures in 5.0 absorbable material (Fig. 54.15A).

Long-lasting dysthyroid restrictions are associated with conjunctival scarring; for this reason muscle recessions should preferably be done through a base fornix conjunctival incision, which permits conjunctival lengthening by means of its recession at the end of surgery (Fig. 54.15B).

Because of the enlarged GO muscles, retroequatorial miopexias can be difficult to perform, unless the ‘faden’ is passed through the sclera after having detached the muscle to be treated from its eye globe insertion. In many case this maneuver does not increase the surgical time as often in dysthyroid strabismus retroequatorial miopexias need to be associated with muscle recessions. A double passage of the ‘faden’ into the sclera is advisable in order to increase the strength of the suture the mechanical action of the oversized muscle (Fig. 54.16).

Cosmetic eyelid surgery

Cosmetic periorbital surgery in GO is substantially similar to that for the aging face (see Chapter 51). Skin removal should, however be more conservative in GO, as skin excess is often more apparent than real in the affected patients. Another difference concerns the treatment of the sub eye brow fat pad. Up until recently, in the aging patient, it was sculptured or resected with the unfortunate effect of taking away the natural fullness of the upper eyelid fold. Nowadays, sub-eyebrow fat repositioning is in general preferred in cosmetic surgery, while it continues to be sculptured or resected when, as in GO, it is pathologically enlarged (Fig. 54.17A–C). In light of the anti-vitamin-K action of commonly used thionamides such as methimazole in patients with GO, sculpturing or excision of the sub-brow fat pad can be assisted by the use of a CO2 laser (Fig. 54.18A–C).

image image image

Fig. 54.18 Surgery on patient in Figure 54.17. (A) The pre-aponeurotic fat pad is exposed through the incised septum and (B) excised. (C) The sub-brow fat pad is excised. (A–C) The procedure is carried out bloodess by means of a CO2 laser.

References

1 Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168-199.

2 Perros P, Dickinson AJ. Ophthalmopathy. In: Braverman LE, Utiger RD, editors. Werner’s and Ingbar’s The Thyroid – A Fundamental and Clinical Text. 9th edn. Philadelphia: Lippincott Williams & Wilkins; 2005:474-487.

3 Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid. 2002;12:855-860.

4 Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev. 2003;24:802-835.

5 Bahn RS. Clinical review 157: Pathophysiology of Graves’ ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab. 2003;88:1939-1946.

6 Ludgate M, Baker G. Inducing Graves’ ophthalmopathy. J Endocrinol Invest. 2004;27:211-215.

7 Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves’ ophthalmopathy. J Endocrinol Invest. 2004;27:237-245.

8 Bartalena L, Wiersinga WM, Pinchera A. Graves’ ophthalmopathy: state of the art and perspectives. J Endocrinol Invest. 2004;27:295-301.

9 Perros P, Crombie AL, Matthews JN, et al. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf). 1993;38:367-372.

10 Bartalena L, Marcocci C, Pinchera A. Graves’ ophthalmopathy: a preventable disease? Eur J Endocrinol. 2002;146:457-461.

11 Rundle FF. Development and course of exophthalmos and ophthalmoplegia in Graves’ disease with special reference to the effect of thyroidectomy. Clin Sci. 1945;5:177-194.

12 Bartalena L, Baldeschi L, Dickinson JA, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Eur J Endocrinol. 2008;158:273-285.

13 Bartalena L, Baldeschi L, Dickinson JA, et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid. 2008;18:333-346.

14 Baldeschi L, Wakelkamp IMMJ, Lindeboom R, et al. Early versus late orbital decompression in Graves’ orbitopathy: a retrospective study in 125 patients. Ophthalmology. 2006;113:874-878.

15 Baldeschi L. Rehabilitative surgery. In: Wiersinga WM, Kahaly GJ, editors. Graves’ Orbitopathy: A Multidisciplinary Approach – Questions and Answers. 2nd edn. Basel: Karger; 2010:167-170.

16 Michel O, Oberländer N, Neugebauer P, et al. Follow-up of transnasal orbital decompression in severe Graves’ ophthalmopathy. Ophthalmology. 2001;108:400-404.

17 Tremolada C, Tremolada MA. The ‘triple technique’ for treating stable Graves’ ophthalmopathy. Plast Reconstr Surg. 1997;100:40-48.

18 Ben Simon GJ, Mansury AM, Schwarcz RM, et al. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology. 2005;112:923-932.

19 Richter DF, Stoff A, Olivari N. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years. Plast Reconstr Surg. 2007;120:109-123.

20 Olivari N. Endocrine ophthalmopathy: Surgical treatment. HNO. 2010;58:8-10. 12–4

21 Chang EL, Rubin PAD. Thyroid orbitopathy. Ophthalmology. 2006;113:718-719.

22 Baldeschi L. Orbital decompression. In: Wiersinga WM, Kahaly GJ, editors. Graves’ Orbitopathy: A Multidisciplinary Approach – Questions and Answers. 2nd edn. Basel: Karger; 2010:171-188.

23 McCord CD. Orbital decompression for Graves’ disease: exposure through lateral canthal and inferior fornix incision. Ophthalmology. 1981;88:533-541.

24 Goldberg RA, Weinberg DA, Schorr N, et al. Maximal 3-wall orbital decompression through a coronal approach. Ophthalmic Surg Lasers. 1997;28:832-843.

25 Baldeschi L. Small versus coronal incision orbital decompression in Graves’ orbitopathy. Orbit. 2010;29:177-182.

26 van der Wal KG, de Visscher JG, Boukes RJ, et al. Surgical treatment of Graves orbitopathy: a modified balanced technique. Int J Oral Maxillofac Surg. 2001;30:254-258.

27 Saks ND, Burnstine MA, Putterman AM. Glabellar rhytids in thyroid-associated orbitopathy. Ophthal Plast Reconstr Surg. 2001;17:91-95.

28 Shorr N, Baylis HI, Goldberg RA, et al. Transcaruncular approach to the medial orbit and orbital apex. Ophthalmology. 2000;107:1459-1463.

29 Kim JW, Kikkawa DO, Lemke BN. Donor site complications of hard palate mucosal grafting. Ophthal Plast Reconstr Surg. 1997;13:36-39.

30 Hintschich C, Haritoglou C. Full thickness eyelid transsection (blepharotomy) for upper eyelid lengthening in lid retraction associated with Graves’ disease. Br J Ophthalmol. 2005;89:413-416.